Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 822.70x is 3147% above its estimated 5-year average of 25.33x, near the low end of its estimated 5-year range (6.03x–4117.04x).
As of 2026-10-06T15:51:14.056Z. 26.78% below its estimated 12-month average of 1123.66x.
Calculation as of: 2026-10-06T15:51:14.056Z.
Quote observation: 2026-10-06T15:50:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a052b5393ab77f1e77aa428053085e4d751b04d668ff3bc446a118ef207c6094
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
822.70x
EV/SALES RATIO AVG TTM
1123.66x
EV/SALES RATIO AVG 3Y
278.21x
EV/SALES RATIO AVG 5Y
25.33x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.78%
CURRENT VS 3Y AVG
+195.71%
CURRENT VS 5Y AVG
+3147.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 455 covered companies
CURRENT VS SECTOR MEDIAN
+19488.10%
vs the sector median at left
Denali Therapeutics Inc.
Market Cap
$3.14B
EV/Sales Ratio
822.70x
TTM Avg
1123.66x
3Y Avg
278.21x
5Y Avg
25.33x
Market Cap
$3.09B
EV/Sales Ratio
6.84x
TTM Avg
9.31x
3Y Avg
10.36x
5Y Avg
140.89x
Market Cap
$3.09B
EV/Sales Ratio
N/A
TTM Avg
1.20x
3Y Avg
895.62x
5Y Avg
895.62x
Market Cap
$3.42B
EV/Sales Ratio
2809.83x
TTM Avg
5544.59x
3Y Avg
5544.59x
5Y Avg
2117.19x
Market Cap
$3.43B
EV/Sales Ratio
2.74x
TTM Avg
3.65x
3Y Avg
3.66x
5Y Avg
4.78x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | $3.14B | 822.70x | 1123.66x | 278.21x | 25.33x |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 6.84x | 9.31x | 10.36x | 140.89x |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 1.20x | 895.62x | 895.62x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.08B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.38B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.87B | N/A | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.42B | 2809.83x | 5544.59x | 5544.59x | 2117.19x |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.43B | 2.74x | 3.65x | 3.66x | 4.78x |
| CareDx, Inc (CDNA)vs › | $3.45B | 6.75x | 3.21x | 2.88x | 3.18x |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 4.81x | 7.37x | 10.06x | 14.84x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 986.52x |
| 2026-10-02 | 991.19x |
| 2026-10-01 | 1018.74x |
| 2026-09-30 | 1026.02x |
| 2026-09-29 | 1033.29x |
| 2026-09-28 | 1042.13x |
| 2026-09-25 | 1011.46x |
| 2026-09-24 | 1015.62x |
| 2026-09-23 | 1015.10x |
| 2026-09-22 | 1074.35x |
| 2026-09-21 | 1015.62x |
| 2026-09-18 | 976.64x |
| 2026-09-17 | 997.95x |
| 2026-09-16 | 994.31x |
| 2026-09-15 | 1010.94x |
| 2026-09-14 | 1054.60x |
| 2026-09-11 | 1047.85x |
| 2026-09-10 | 1063.96x |
| 2026-09-09 | 1072.79x |
| 2026-09-08 | 1099.30x |
| 2026-09-04 | 1109.70x |
| 2026-09-03 | 1136.72x |
| 2026-09-02 | 1139.32x |
| 2026-09-01 | 1161.15x |
| 2026-08-31 | 1186.62x |
| 2026-08-28 | 1199.09x |
| 2026-08-27 | 1233.91x |
| 2026-08-26 | 1228.72x |
| 2026-08-25 | 1247.43x |
| 2026-08-24 | 1209.49x |
| 2026-08-21 | 1246.91x |
| 2026-08-20 | 1248.47x |
| 2026-08-19 | 1286.93x |
| 2026-08-18 | 1215.20x |
| 2026-08-17 | 1217.28x |
| 2026-08-14 | 1219.88x |
| 2026-08-13 | 1241.71x |
| 2026-08-12 | 1265.10x |
| 2026-08-11 | 1234.95x |
| 2026-08-10 | 1251.06x |
| 2026-08-07 | 1242.23x |
| 2024-11-06 | 3917.16x |
| 2024-11-05 | 3663.98x |
| 2024-11-04 | 3605.35x |
| 2024-11-01 | 3584.03x |
| 2024-10-31 | 3438.78x |
| 2024-10-30 | 3557.38x |
| 2024-10-29 | 3639.99x |
| 2024-10-28 | 3681.30x |
| 2024-10-25 | 3464.10x |
| 2024-10-24 | 3502.74x |
| 2024-10-23 | 3454.77x |
| 2024-10-22 | 3482.75x |
| 2024-10-21 | 3494.75x |
| 2024-10-18 | 3655.98x |
| 2024-10-17 | 3633.33x |
| 2024-10-16 | 3665.31x |
| 2024-10-15 | 3557.38x |
| 2024-10-14 | 3554.71x |
| 2024-10-11 | 3710.62x |
| 2024-10-10 | 3409.46x |
| 2024-10-09 | 3513.40x |
| 2024-10-08 | 3541.38x |
| 2024-10-07 | 3524.06x |
| 2024-10-04 | 3794.57x |
| 2024-10-03 | 3739.93x |
| 2024-10-02 | 3847.87x |
| 2024-10-01 | 3799.90x |
| 2024-09-30 | 3861.19x |
| 2024-09-27 | 3901.17x |
| 2024-09-26 | 3879.85x |
| 2024-09-25 | 3843.87x |
| 2024-09-24 | 4019.76x |
| 2024-09-23 | 4009.10x |
| 2024-09-20 | 4098.38x |
| 2024-09-19 | 4117.04x |
| 2024-09-18 | 4078.39x |
| 2024-09-17 | 4067.73x |
| 2024-09-16 | 4021.09x |
| 2024-09-13 | 4079.73x |
| 2024-09-12 | 3705.29x |
| 2024-09-11 | 3588.02x |
| 2024-09-10 | 3489.42x |
| 2024-09-09 | 3389.48x |
| 2024-09-06 | 3344.17x |
| 2024-09-05 | 3344.17x |
| 2024-09-04 | 3332.18x |
| 2024-09-03 | 3326.85x |
| 2024-08-30 | 3236.24x |
| 2024-08-29 | 3230.91x |
| 2024-08-28 | 3245.56x |
| 2024-08-27 | 3306.86x |
| 2024-08-26 | 3390.81x |
| 2024-08-23 | 3280.21x |
| 2024-08-22 | 3162.95x |
| 2024-08-21 | 3310.86x |
| 2024-08-20 | 3130.97x |
| 2024-08-19 | 3170.94x |
| 2024-08-16 | 3047.02x |
| 2024-08-15 | 3133.63x |
| 2024-08-14 | 2975.06x |
| 2024-08-13 | 3047.02x |
| 2024-08-12 | 2980.39x |
| 2024-08-09 | 2963.07x |
| 2024-08-08 | 2948.41x |
| 2024-08-07 | 2868.46x |
| 2024-08-06 | 2911.10x |
| 2024-08-05 | 2863.13x |
| 2024-08-02 | 2893.78x |
| 2024-08-01 | 11.77x |
| 2024-07-31 | 12.29x |
| 2024-07-30 | 12.21x |
| 2024-07-29 | 12.30x |
| 2024-07-26 | 12.16x |
| 2024-07-25 | 12.15x |
| 2024-07-24 | 11.91x |
| 2024-07-23 | 12.04x |
| 2024-07-22 | 11.87x |
| 2024-07-19 | 10.82x |
| 2024-07-18 | 10.98x |
| 2024-07-17 | 11.60x |
| 2024-07-16 | 12.07x |
| 2024-07-15 | 11.77x |
| 2024-07-12 | 11.53x |
| 2024-07-11 | 11.64x |
| 2024-07-10 | 10.92x |
| 2024-07-09 | 10.57x |
| 2024-07-08 | 10.68x |
| 2024-07-05 | 10.66x |
| 2024-07-03 | 10.74x |
| 2024-07-02 | 10.96x |
| 2024-07-01 | 11.10x |
| 2024-06-28 | 11.71x |
| 2024-06-27 | 11.58x |
| 2024-06-26 | 11.09x |
| 2024-06-25 | 11.29x |
| 2024-06-24 | 11.55x |
| 2024-06-21 | 11.41x |
| 2024-06-20 | 10.79x |
| 2024-06-18 | 10.40x |
| 2024-06-17 | 10.32x |
| 2024-06-14 | 10.45x |
| 2024-06-13 | 11.15x |
| 2024-06-12 | 10.86x |
| 2024-06-11 | 10.89x |
| 2024-06-10 | 10.60x |
| 2024-06-07 | 10.47x |
| 2024-06-06 | 10.74x |
| 2024-06-05 | 11.02x |
| 2024-06-04 | 10.42x |
| 2024-06-03 | 10.27x |
| 2024-05-31 | 9.35x |
| 2024-05-30 | 9.30x |
| 2024-05-29 | 9.09x |
| 2024-05-28 | 9.53x |
| 2024-05-24 | 9.68x |
| 2024-05-23 | 9.71x |
| 2024-05-22 | 10.11x |
| 2024-05-21 | 10.07x |
| 2024-05-20 | 10.15x |
| 2024-05-17 | 10.34x |
| 2024-05-16 | 10.20x |
| 2024-05-15 | 10.52x |
| 2024-05-14 | 9.96x |
| 2024-05-13 | 9.73x |
| 2024-05-10 | 9.23x |
| 2024-05-09 | 9.41x |
| 2024-05-08 | 9.53x |
| 2024-05-07 | 6.82x |
| 2024-05-06 | 6.94x |
| 2024-05-03 | 6.94x |
| 2024-05-02 | 6.80x |
| 2024-05-01 | 6.53x |
| 2024-04-30 | 6.23x |
| 2024-04-29 | 6.30x |
| 2024-04-26 | 6.23x |
| 2024-04-25 | 6.03x |
| 2024-04-24 | 6.28x |
| 2024-04-23 | 6.51x |
| 2024-04-22 | 6.46x |
| 2024-04-19 | 6.47x |
| 2024-04-18 | 6.72x |
| 2024-04-17 | 6.81x |
| 2024-04-16 | 7.03x |
| 2024-04-15 | 7.24x |
| 2024-04-12 | 7.41x |
| 2024-04-11 | 7.79x |
| 2024-04-10 | 7.48x |
| 2024-04-09 | 7.90x |
| 2024-04-08 | 7.74x |
| 2024-04-05 | 7.88x |
| 2024-04-04 | 7.72x |
| 2024-04-03 | 7.88x |
| 2024-04-02 | 7.88x |
| 2024-04-01 | 8.37x |
| 2024-03-28 | 8.36x |
| 2024-03-27 | 8.46x |
| 2024-03-26 | 8.09x |
| 2024-03-25 | 8.08x |
| 2024-03-22 | 7.98x |
| 2024-03-21 | 8.56x |
| 2024-03-20 | 8.68x |
| 2024-03-19 | 8.36x |
| 2024-03-18 | 8.18x |
| 2024-03-15 | 8.19x |
| 2024-03-14 | 8.03x |
| 2024-03-13 | 8.51x |
| 2024-03-12 | 8.46x |
| 2024-03-11 | 8.85x |
| 2024-03-08 | 8.53x |
| 2024-03-07 | 8.36x |
| 2024-03-06 | 8.36x |
| 2024-03-05 | 8.33x |
| 2024-03-04 | 8.41x |
| 2024-03-01 | 8.50x |
| 2024-02-29 | 8.05x |
| 2024-02-28 | 8.23x |
| 2024-02-27 | 9.15x |
| 2024-02-26 | 6.55x |
| 2024-02-23 | 6.56x |
| 2024-02-22 | 6.52x |
| 2024-02-21 | 6.40x |
| 2024-02-20 | 6.40x |
| 2024-02-16 | 6.60x |
| 2024-02-15 | 7.14x |
| 2024-02-14 | 6.95x |
| 2024-02-13 | 6.61x |
| 2024-02-12 | 7.22x |
| 2024-02-09 | 7.01x |
| 2024-02-08 | 6.67x |
| 2024-02-07 | 6.57x |
| 2024-02-06 | 6.44x |
| 2024-02-05 | 6.12x |
| 2024-02-02 | 6.21x |
| 2024-02-01 | 6.34x |
| 2024-01-31 | 6.19x |
| 2024-01-30 | 6.47x |
| 2024-01-29 | 6.80x |
| 2024-01-26 | 6.54x |
| 2024-01-25 | 6.67x |
| 2024-01-24 | 6.63x |
| 2024-01-23 | 6.63x |
| 2024-01-22 | 6.72x |
| 2024-01-19 | 6.63x |
| 2024-01-18 | 6.48x |
| 2024-01-17 | 6.64x |
| 2024-01-16 | 7.14x |
| 2024-01-12 | 7.21x |
| 2024-01-11 | 7.27x |
| 2024-01-10 | 7.31x |
| 2024-01-09 | 7.70x |
| 2024-01-08 | 7.95x |
| 2024-01-05 | 7.53x |
| 2024-01-04 | 7.91x |
| 2024-01-03 | 7.93x |
| 2024-01-02 | 8.36x |
| 2023-12-29 | 8.39x |
| 2023-12-28 | 8.59x |
| 2023-12-27 | 8.69x |
| 2023-12-26 | 8.75x |
Showing the most recent 260 of 1,631 data points. The chart above shows the full history.
